Bebtelovimab: The FDA-approved Monoclonal Antibody for Treating Patients with Mild-to-Moderate COVID-19

Thumbnail Image

Files

tms-2-3-130706.pdf (87.54 KB)

Date

2022-08-31

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Brieflands

Abstract

This article does not have an abstract.

Description

Keywords

Citation

URI

Collections

Trends in Medical Sciences

Endorsement

Review

Supplemented By

Referenced By